Cramer: Goldman's Downgrade Of J&J Is 'Questionable'
Johnson & Johnson had a very good acquisition
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer thought the Goldman Sachs (GS) - Get Report downgrade of Johnson & Johnson (JNJ) - Get Report was questionable. Johnson & Johnson had a very good acquisition and Cramer doesn't advice people to sell and then get back in at $127.
Watch More with TheStreet:
- Fed's Balance Sheet Plans Won't Interrupt the Strong Corporate Earnings Story
- The Best Companies for Women
- You Can Become a Millionaire Even if You Make $35,000 a Year
- How Healthy Is That Happy Meal? Inside the Kids' Menus at McDonald's and More
Loading ...